SCPH Annual Net Income
-$54.81 M
-$17.97 M-48.79%
31 December 2023
Summary:
As of January 23, 2025, SCPH annual net profit is -$54.81 million, with the most recent change of -$17.97 million (-48.79%) on December 31, 2023. During the last 3 years, it has fallen by -$22.60 million (-70.17%). SCPH annual net income is now -421.11% below its all-time high of -$10.52 million, reached on December 31, 2015.SCPH Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCPH Quarterly Net Income
-$35.10 M
-$18.02 M-105.41%
30 September 2024
Summary:
As of January 23, 2025, SCPH quarterly net profit is -$35.10 million, with the most recent change of -$18.02 million (-105.41%) on September 30, 2024. Over the past year, it has dropped by -$21.29 million (-154.16%). SCPH quarterly net income is now -614.68% below its all-time high of -$4.91 million, reached on March 31, 2017.SCPH Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCPH TTM Net Income
-$80.11 M
-$19.47 M-32.11%
30 September 2024
Summary:
As of January 23, 2025, SCPH TTM net profit is -$80.11 million, with the most recent change of -$19.47 million (-32.11%) on September 30, 2024. Over the past year, it has dropped by -$25.30 million (-46.17%). SCPH TTM net income is now -1406.49% below its all-time high of -$5.32 million, reached on December 31, 2016.SCPH TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SCPH Net Income Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -48.8% | -154.2% | -46.2% |
| 3 y3 years | -70.2% | -279.6% | -117.5% |
| 5 y5 years | -86.2% | -279.6% | -117.5% |
SCPH Net Income High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -95.5% | at low | -379.7% | at low | -185.8% | at low |
| 5 y | 5-year | -95.5% | at low | -435.8% | at low | -185.8% | at low |
| alltime | all time | -421.1% | at low | -614.7% | at low | -1406.5% | at low |
ScPharmaceuticals Net Income History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$35.10 M(+105.4%) | -$80.11 M(+32.1%) |
| June 2024 | - | -$17.09 M(+21.1%) | -$60.64 M(+5.1%) |
| Mar 2024 | - | -$14.11 M(+2.1%) | -$57.71 M(+5.3%) |
| Dec 2023 | -$54.81 M(+48.8%) | -$13.81 M(-11.7%) | -$54.81 M(+9.1%) |
| Sept 2023 | - | -$15.63 M(+10.5%) | -$50.25 M(+12.2%) |
| June 2023 | - | -$14.15 M(+26.3%) | -$44.77 M(+11.1%) |
| Mar 2023 | - | -$11.21 M(+21.2%) | -$40.32 M(+9.4%) |
| Dec 2022 | -$36.84 M(+31.4%) | -$9.25 M(-9.0%) | -$36.84 M(+5.5%) |
| Sept 2022 | - | -$10.16 M(+4.8%) | -$34.91 M(+11.5%) |
| June 2022 | - | -$9.70 M(+25.4%) | -$31.30 M(+9.2%) |
| Mar 2022 | - | -$7.73 M(+5.6%) | -$28.66 M(+2.2%) |
| Dec 2021 | -$28.03 M(-13.0%) | -$7.32 M(+11.7%) | -$28.03 M(-1.6%) |
| Sept 2021 | - | -$6.55 M(-7.2%) | -$28.50 M(-8.0%) |
| June 2021 | - | -$7.06 M(-0.6%) | -$30.99 M(-3.8%) |
| Mar 2021 | - | -$7.10 M(-8.8%) | -$32.22 M(+0.0%) |
| Dec 2020 | -$32.21 M | -$7.78 M(-13.9%) | -$32.21 M(-8.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | -$9.04 M(+9.0%) | -$35.24 M(+8.7%) |
| June 2020 | - | -$8.29 M(+17.0%) | -$32.41 M(+3.3%) |
| Mar 2020 | - | -$7.09 M(-34.4%) | -$31.37 M(-4.9%) |
| Dec 2019 | -$33.00 M(+12.1%) | -$10.81 M(+74.2%) | -$32.99 M(+20.9%) |
| Sept 2019 | - | -$6.21 M(-14.4%) | -$27.28 M(+1.7%) |
| June 2019 | - | -$7.25 M(-16.8%) | -$26.84 M(-8.8%) |
| Mar 2019 | - | -$8.72 M(+71.0%) | -$29.43 M(-0.0%) |
| Dec 2018 | -$29.44 M(+23.6%) | -$5.10 M(-11.5%) | -$29.44 M(-5.7%) |
| Sept 2018 | - | -$5.76 M(-41.5%) | -$31.22 M(+0.9%) |
| June 2018 | - | -$9.85 M(+12.8%) | -$30.95 M(+12.0%) |
| Mar 2018 | - | -$8.73 M(+26.9%) | -$27.64 M(+16.0%) |
| Dec 2017 | -$23.82 M(-2.3%) | -$6.88 M(+25.3%) | -$23.82 M(+7.0%) |
| Sept 2017 | - | -$5.49 M(-16.0%) | -$22.25 M(+32.7%) |
| June 2017 | - | -$6.54 M(+33.1%) | -$16.77 M(+63.9%) |
| Mar 2017 | - | -$4.91 M(-7.6%) | -$10.23 M(+92.4%) |
| Dec 2016 | -$24.38 M(+131.8%) | -$5.32 M | -$5.32 M |
| Dec 2015 | -$10.52 M | - | - |
FAQ
- What is scPharmaceuticals annual net profit?
- What is the all time high annual net income for scPharmaceuticals?
- What is scPharmaceuticals annual net income year-on-year change?
- What is scPharmaceuticals quarterly net profit?
- What is the all time high quarterly net income for scPharmaceuticals?
- What is scPharmaceuticals quarterly net income year-on-year change?
- What is scPharmaceuticals TTM net profit?
- What is the all time high TTM net income for scPharmaceuticals?
- What is scPharmaceuticals TTM net income year-on-year change?
What is scPharmaceuticals annual net profit?
The current annual net income of SCPH is -$54.81 M
What is the all time high annual net income for scPharmaceuticals?
scPharmaceuticals all-time high annual net profit is -$10.52 M
What is scPharmaceuticals annual net income year-on-year change?
Over the past year, SCPH annual net profit has changed by -$17.97 M (-48.79%)
What is scPharmaceuticals quarterly net profit?
The current quarterly net income of SCPH is -$35.10 M
What is the all time high quarterly net income for scPharmaceuticals?
scPharmaceuticals all-time high quarterly net profit is -$4.91 M
What is scPharmaceuticals quarterly net income year-on-year change?
Over the past year, SCPH quarterly net profit has changed by -$21.29 M (-154.16%)
What is scPharmaceuticals TTM net profit?
The current TTM net income of SCPH is -$80.11 M
What is the all time high TTM net income for scPharmaceuticals?
scPharmaceuticals all-time high TTM net profit is -$5.32 M
What is scPharmaceuticals TTM net income year-on-year change?
Over the past year, SCPH TTM net profit has changed by -$25.30 M (-46.17%)